BridgeMD
Compares treatment options for Hepatocellular Carcinoma
Official title Impact of Propofol-Based Total Intravenous Anesthesia Versus Anesthesia With Sevoflurane on Long-term Outcomes With Patients Undergoing Elective Excision of Primary Liver Tumors
ClinicalTrials.gov ID: NCT05331911
What this study is testing
What is Propofol?
Propofol is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for hepatocellular carcinoma.
Also referred to as total intravenous anesthesia.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This is a two-arm, parallel-group randomized clinical trial. Routine perioperative care would be performed in volunteers with primary Hepatocellular carcinoma.
- Phase 4: studies an already-approved treatment
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 80
You may be able to join if
- Twenty to eighty-year-old.
- ASA class I-III.
- Patients undergoing partial hepatectomy for hepatocellular carcinoma under general anesthesia.
You likely can't join if
- Severe mental disorder
- Pregnant or lactating women
- Morbidly obese
- Allergy to any of the drugs used in this study
- Recurrent tumor or repeat surgery
- Biopsy cases
See the full eligibility criteria
- Twenty to eighty-year-old.
- ASA class I-III.
- Patients undergoing partial hepatectomy for hepatocellular carcinoma under general anesthesia.
- Severe mental disorder
- Pregnant or lactating women
- Morbidly obese
- Allergy to any of the drugs used in this study
- Recurrent tumor or repeat surgery
- Biopsy cases
- Incomplete data collection before the surgery
- Palliative treatment after surgery
- simultaneous treatment of other malignancies
- Combined propofol and inhalation anesthesia or other anesthetics, such as ketamine or dexmedetomidine
- Diagnosed as benign liver tumor
- Emergency surgery
The study team makes the final eligibility decision.
Where it's taking place
- Kaohsiung City, Taiwan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kaohsiung City, Taiwan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.